Mitomycin (MMC)

DRUG3 trials

Sponsors

Wills Eye, Second Military Medical University, Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Conditions

Advanced Hepatocellular CarcinomaAnal Squamous Cell Carcinoma, Limited-stageGlaucomaRecurrence Hepatocellular Carcinoma

Phase 1

Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma

Second Military Medical UniversityAdvanced Hepatocellular Carcinoma, Recurrence Hepatocellular Carcinoma

Start: 2015-09-30End: 2017-09-30Target: 60Updated: 2016-01-01

Phase 2

Lucentis Versus Mitomycin C During Glaucoma Surgery

CompletedNCT00626782

Wills EyeGlaucoma

Start: 2008-01-31End: 2011-04-30Updated: 2018-03-22

Phase 3

Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell Carcinoma

RecruitingNCT07692152

Cancer Institute and Hospital, Chinese Academy of Medical SciencesAnal Squamous Cell Carcinoma, Limited-stage

Start: 2026-03-17End: 2029-03-01Target: 350Updated: 2026-07-09